Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$86.23K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Lotus Pharmaceuticals, Inc.Lotus Pharmaceuticals, Inc.-336-20%--1
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$86,230.00
Enterprise Value$209,244.00
Earnings per Share$0
Beta-1.52
Outstanding Shares2,644,515,543

Return

Return on Equity20.46%ROE
Return on Assets-581.11%
Return on Invested Capital20.46%

Valuation & Multiples

P/E Ratio-335.97P/E Ratio
PEG499.1PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-8.58
Enterprise Value to Net Income-9
Total Debt to Enterprise0.59
Debt to Equity-1.04Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 9, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Lotus Pharmaceuticals, Inc.

233 employees
CEO: Zhong Yi Liu

Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.